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Saccess may increase the time required, patient discomfort, risk of arterial spasm, and
the need for cross-over to other access sites. Ultrasound (US) guidance has been
demonstrated to facilitate vascular access and reduce vascular complications in
multiple sites and locations, but has not been tested in a multicenter fashion in
transradial access.
Methods: We conducted a multicenter randomized controlled trial of 473 patients
undergoing transradial cardiac catheterization. Four centers (6 hospitals) and 16
operators trained in US guidance participated in the study. Patients were randomized
to needle insertion with either palpation (P) or real-time US guidance (237 P, 236 US).
Primary endpoints were the number of forward attempts required for access, ﬁrst pass
success rate, and time to sheath insertion.
Results: The mean number of attempts was reduced with US guidance (1.65  1.2 vs.
3.05  3.4, p< 0.0001) and the ﬁrst pass success rate improved (64.8% vs. 43.9%,
p< 0.0001). The mean time to sheath insertion was reduced (83  78 vs. 113 
124 seconds, p¼0.0016) as was the median time to insertion (60 [IQR 42-91] vs.
75 [50-119], p<0.005). Ten patients in the control group required cross-over
to US guidance after 5 minutes of failed palpation attempts with 9/10 (90%)
having successful sheath insertion with US. The number of difﬁcult access
procedures was decreased with US guidance (6 vs. 44 for > 5 attempts, p <0.001; 6
vs. 15 for > 5min, p¼0.07). There was no signiﬁcant difference in the rate of operator-
reported spasm (4.2% P vs. 5.5% US, p¼0.53), crossover to other access sites (2.5%
P vs. 1.3% US, p¼0.34), mean patient pain scores (range 0-10) following the
procedure (0.82 P vs. 0.89 US, p¼0.29), or bleeding complications (1.7% P vs. 2.1%
US, p¼0.75).
Conclusions: Ultrasound guidance improves the success and efﬁciency of
radial artery cannulation in patients presenting for transradial catheterization.
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Background: One of the more recent treatment options for femoro-popliteal,
atherosclerotic lesions, is the application of self-expanding nitinol stents. The use
of 4 French systems, can reduce access site related complications. Although there
are clear indications of the beneﬁts of 4F devices for peripheral applications,
scientiﬁc evidence to support this thesis are still lacking today. The 4EVER trial
attempts to investigate the long-term results (up to 24 months) in patients pre-
senting with intermittent claudication or critical limb ischemia by use of 4 French
systems.
Methods: The 4EVER trial is a prospective, non-randomized, multi-center, multi-
national, controlled trial conducted in 5 sites in Belgium and Germany. Between June
2010 and May 2011, 120 patients were enrolled. The primary endpoint was primary
patency at 12 months, deﬁned as freedom from >50% restenosis at 12 months as
indicated by an independently veriﬁed duplex ultrasound peak systolic velocity ratio
(PSVR) <2.5 in the target vessel with no reintervention.
Results: Of the 120 patients enrolled, 82 (68.33%) were men and the mean age was
71 (47-90; 9.70) years. 83.33% had intermittent claudication and 16.67% pre-
sented with critical limb ischemia. For lesion treatment, 70 (58.33%) patients
received an Astron Pulsar stent, 46 (38.33%) were treated with Pulsar-18 stent
placement and 4 (3.33%) received mixed stent use. The mean lesion length was
43.50mm in the Astron Pulsar group, 105.44mm in the Pulsar-18 group and
145.00mm in the mixed stent group. Kaplan Meier estimation reported a 6-month
primary patency rate of 90.0% and a 6-month freedom of target lesion revascu-
larization of 95.4%. Primary patency rates for the Astron Pulsar group, Pulsar-18
group and mixed stent group at 6 months were 92.2%, 85.3% and 100% respec-
tively. For 103 patients, compression time was recorded with a mean compression
time of 8.12 (2.00-15.00) minutes.
Conclusions: With a high primary patency at 6 months and a low compression time,
this ﬁrst analysis indicates the beneﬁts of treatment with 4 French systems. As these
ﬁrst preliminary 6-month data show promising results, full 12-month data will be
presented at TCT 2013.TCT-280
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Background: The transradial approach has been accepted as an alternative entry
method for coronary angiography and angioplasty. However, this procedure carries
a risk of injury to the endothelium in the radial artery. Flow-mediated dilation (FMD)
has often been used to investigate vascular endothelial function, and some reportsJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrhave examined the impact of catheter sheath insertion on vascular function using this
method. However, the assessment is limited in that the focus is on only one point of
the brachial or radial artery. Reactive hyperemia peripheral arterial tonometry (RH-
PAT) has recently been developed for the assessment of endothelial function in
peripheral arteries, offering higher reproducibility and easier manipulation. The aim of
this study was to examine vascular dysfunction caused by catheter sheath insertion
into a radial artery using RH-PAT and to compare differences in injuries according to
the size of sheath.
Methods: RH-PAT was measured using an Endo-PAT2000 system. Forty-three
patients receiving transradial catheterization with 6-Fr sheaths (n¼17) or 4-Fr/5-Fr
(n¼26) sheaths underwent Endo-PAT2000 before and the day after catheterization.
RH-PAT was assessed in the arm of sheath placement and in the other arm as
a control. Thirteen subjects in the 6-Fr group were reassessed using RH-PAT at 6
months after catheterization.
Results: RH-PAT values decreased from 2.420.67 before catheterization to
2.080.41 the day after catheterization in the 6-Fr group (p<0.05), while the
change in the non-6-Fr (4-Fr/5-Fr) group was not signiﬁcant (from 2.220.56 to
2.080.61; p¼0.24). In both groups, RH-PAT of the non-catheterized arm was
unchanged. At 6 months after catheterization, RHI-PAT values had not returned to
baseline (2.590.68 before catheterization and 2.240.47 at 6 months after cathe-
terization; p¼0.138).
Conclusions: Insertion of a 6-Fr catheter sheath into the radial artery impairs vascular
endothelial function as assessed by RH-PAT. In addition, such injuries do not recover
completely within 6 months. These ﬁndings suggest that smaller sheaths (<6-Fr)
should be used to prevent severe endothelial dysfunction in the radial artery during
transradial catheterization.
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Background: Access site difﬁculties are a major cause of complications follo-
wing TAVI procedures. Different techniques have been proposed to optimize the
femoral hemostasis, advancing an angioplasty wire from the ipsilateral or con-
tralateral femoral artery in cases of vascular complications. However, once the
complication is in place, it may be difﬁcult to cross the bleeding point with a wire.
This study sought to evaluate the usefulness of a systematic "Crossover wire
Technique" advanced from the contralateral femoral artery at the beginning of the
procedure, to manage potential vascular complications and to improve the hemostasis
during TAVI procedures.
Methods: Retrospective analysis of 159 patients undergoing TAVI with 18F intro-
ducer and percutaneous closure with Prostar device were analyzed. Patients were
divided into 2 sequential groups: group I ("without wire", n¼57, treated up to July
2010) and group II (n¼112), including patients since August 2010 that underwent the
"Crossover wire technique". Pre-procedural variables, complications (VARC-2
criteria) and treatment were compared.
Results: Results are expressed in the table. Total number of vascular complications
was similar in both groups. Prostar closure failure resulted the most frequent
complication. Life threatening bleedings (3 vs 12%, p¼0.04), major vascular
complications (7 vs 18%, p¼0.04) and mortality (6 vs 18%) were lower in group II.
Surgical repair was undertaken more frequently in group I (7 vs 1%, p¼0.06) while
a percutaneous management with covered stent implantation was preferred in group II
(21 vs 9%, p¼0.05).
Conclusions: The "Crossover wire technique" does not reduce the incidence of
vascular complications but decreases their severity and clinical impact, facili-
tating a percutaneous resolution. The team experience might have inﬂuenced in the
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